血清肝素结合蛋白预测脓毒患者发生急性肾损伤的价值

顾小宇, 丁政. 血清肝素结合蛋白预测脓毒患者发生急性肾损伤的价值[J]. 临床急诊杂志, 2021, 22(11): 727-732. doi: 10.13201/j.issn.1009-5918.2021.11.005
引用本文: 顾小宇, 丁政. 血清肝素结合蛋白预测脓毒患者发生急性肾损伤的价值[J]. 临床急诊杂志, 2021, 22(11): 727-732. doi: 10.13201/j.issn.1009-5918.2021.11.005
GU Xiaoyu, DING Zheng. Value of serum heparin binding protein in predicting acute kidney injury in patients with sepsis[J]. J Clin Emerg, 2021, 22(11): 727-732. doi: 10.13201/j.issn.1009-5918.2021.11.005
Citation: GU Xiaoyu, DING Zheng. Value of serum heparin binding protein in predicting acute kidney injury in patients with sepsis[J]. J Clin Emerg, 2021, 22(11): 727-732. doi: 10.13201/j.issn.1009-5918.2021.11.005

血清肝素结合蛋白预测脓毒患者发生急性肾损伤的价值

  • 基金项目:

    江苏省第十五批“六大人才高峰”高层次人才选拔培养资助项目(No:WSN-041)

详细信息
    通讯作者: 丁政,E-mail:gjdti854@163.com
  • 中图分类号: R631.1

Value of serum heparin binding protein in predicting acute kidney injury in patients with sepsis

More Information
  • 目的:评价血清肝素结合蛋白(HBP)预测脓毒症患者发生急性肾损伤(AKI)的价值。方法:选择2019年5月-2021年5月期间入我院首次确诊的152例脓毒症患者,住院期间73例发生AKI(AKI组),79例未发生AKI(无AKI组)。比较两组血清HBP水平,多因素Logistic回归分析筛选AKI的危险因素。结果:与无AKI组相比,AKI组序贯性器官功能衰竭(SOFA)评分、白血胞计数、C反应蛋白(CRP)、N-端脑利钠肽前体(NT-proBNP)和HBP水平显著升高,而肾小球滤过率(GFR)降低,差异有统计学意义(P<0.05)。Logistic回归分析显示,SOFA评分 ≥ 4、NT-proBNP ≥ 2565 ng/L和HBP ≥ 36.5 pg/mL是AKI发生的独立危险因素(P<0.05)。Spearman检验显示,HBP与SOFA评分和NT-proBNP水平呈现正相关(P<0.05)。受试者工作曲线(ROC)显示,HBP预测AKI的曲线下面积(AUC)为0.865,显著高于NT-proBNP的0.644,但与SOFA评分的0.877相比,差异无统计学意义(P>0.05)。结论:血清HBP升高提示脓毒症患者发生AKI风险增加,是早期预测AKI的重要潜力量化指标。
  • 加载中
  • [1]

    Peerapornratana S,Manrique-Caballero CL,Gómez H,et al.Acute kidney injury from sepsis:current concepts,epidemiology,pathophysiology,prevention and treatment[J].Kidney Int,2019,96(5):1083-1099.

    [2]

    陈城,崔静,纪小奇,等.脓毒性休克并发急性肾损伤的危险因素研究[J].蚌埠医学院学报,2021,46(5):639-641.

    [3]

    Kellum JA,Wen X,de Caestecker MP,et al.Sepsis-Associated Acute Kidney Injury:A Problem Deserving of New Solutions[J].Nephron,2019,143(3):174-178.

    [4]

    康凌垲,李小悦,张倩.脓毒症相关急性肾损伤发病机制和新型生物标志物研究进展[J].实用医学杂志,2021,37(6):705-708.

    [5]

    李莫振,尉玉杰,高静.脓毒症患者并发急性肾损伤的风险预测列线图模型建立[J].安徽医学,2021,42(2):179-182.

    [6]

    周明明,蒋正英,李蕊,等.血清胱抑素C联合尿白介素18对脓毒症并发急性肾损伤的早期预测价值[J].中国全科医学,2016,19(8):898-902.

    [7]

    黄楔山,孙自国,李艳,等.尿肾损伤分子-1和可溶性髓样细胞触发受体-1对脓毒症相关急性肾损伤的早期诊断价值[J].临床急诊杂志,2020,21(6):488-492,498.

    [8]

    冯倩茹,张铮.肝素结合蛋白在急危重症疾病中的作用研究进展[J].现代医学,2019,47(7):877-880.

    [9]

    肖薇薇,肖雯,邹联洪,等.肝素结合蛋白在脓毒症大鼠模型严重程度及抗生素应用中的研究[J].实用休克杂志(中英文),2019,3(6):336-339.

    [10]

    Singer M,Deutschman CS,Seymour CW,et al.The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J].JAMA,2016,315(8):801-810.

    [11]

    蒋芬,文南萍,莫红艳,等.重症监护病房患者急性肾损伤KDIGO与AKIN两种标准的应用比较[J].临床急诊杂志,2021,22(3):208-211.

    [12]

    Chen M,Yuan J,Yang Z,et al.Value of heparin-binding protein in diagnosis of sepsis in adult patients:a Meta-analysis[J].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2019,31(10):1224-1230.

    [13]

    庄苏园,聂时南.脓毒症相关急性肾损伤早期生物标记物的研究进展[J].医学研究生学报,2021,34(2):211-216.

    [14]

    Kahn F,Tverring J,Mellhammar L,et al.HeparinBinding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency Department[J].Shock,2019,52(6):e135-e145.

    [15]

    Halldorsdottir HD,Eriksson J,Persson BP,et al.Heparin-binding protein as a biomarker of post-injury sepsis in trauma patients[J].Acta Anaesthesiol Scand,2018,62(7):962-973.

    [16]

    Honore PM,De Bels D,Barreto Gutierrez L,et al.Heparin-binding protein in sepsis:player!predictor!positioning?[J].Ann Intensive Care,2019,9(1):71.

    [17]

    Fisher J,Linder A.Heparin-binding protein:a key player in the pathophysiology of organ dysfunction in sepsis[J].J Intern Med,2017,281(6):562-574.

    [18]

    金大勇,肖芝华,陈斌,等.血清内毒素、肝素结合蛋白与血白细胞计数联合检测在行经皮肾镜碎石术后脓毒症患者中的诊断价值[J].现代医学,2019,47(2):183-186.

    [19]

    Bergquist M,Samuelsson L,Larsson A,et al.TNFR1,TNFR2,neutrophil gelatinase-associated lipocalin and heparin binding protein in identifying sepsis and predicting outcome in an intensive care cohort[J].Sci Rep,2020,10(1):15350.

    [20]

    Fisher J,Russell JA,Bentzer P,et al.Heparin-Binding Protein(HBP):A Causative Marker and Potential Target for Heparin Treatment of Human Sepsis-Induced Acute Kidney Injury[J].Shock,2017,48(3):313-320.

    [21]

    Fisher J,Linder A,Bentzer P,et al.Is Heparin-Binding Protein Inhibition a Mechanism of Albumin's Efficacy in Human Septic Shock?[J].Crit Care Med,2018,46(5):e364-e374.

    [22]

    Tverring J,Vaara ST,Fisher J,et al.Heparin-binding protein(HBP)improves prediction of sepsis-related acute kidney injury[J].Ann Intensive Care,2017,7(1):105.

    [23]

    黄亚军,顾玥,张文雯,等.肝素结合蛋白在脓毒症相关急性肾损伤早期诊断中的价值[J].中华实用诊断与治疗杂志,2021,35(5):436-440.

    [24]

    Xing L,Zhongqian L,Chunmei S,et al.Activation of M1 macrophages in sepsis-induced acute kidney injury in response to heparin-binding protein[J].PLoS One,2018,13(5):e0196423.

    [25]

    Tydén J,Herwald H,Hultin M,et al.Heparin-binding protein as a biomarker of acute kidney injury in critical illness[J].Acta Anaesthesiol Scand,2017,61(7):797-803.

    [26]

    付明月,窦炜,李万瑀,等.白细胞介素-6及肝素结合蛋白与降钙素原预测急性胰腺炎合并腹腔感染的价值[J].中华医院感染学杂志,2021,31(15):2327-2331.

    [27]

    秦华丽,朱芳衡.肝素联合柴胡对内毒素诱导大鼠肾损伤的保护作用[J].海南医学,2019,30(16):2041-2044.

    [28]

    Yang Y,Liu G,He Q,et al.A Promising Candidate:Heparin-Binding Protein Steps onto the Stage of Sepsis Prediction[J].J Immunol Res,2019,2019:7515346.

  • 加载中
计量
  • 文章访问数:  224
  • PDF下载数:  125
  • 施引文献:  0
出版历程
收稿日期:  2021-07-29

目录